GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Hisamitsu Pharmaceutical Co Inc (TSE:4530) » Definitions » Revenue

Hisamitsu Pharmaceutical Co (TSE:4530) Revenue : 円150,185 Mil (TTM As of Aug. 2024)


View and export this data going back to 1962. Start your Free Trial

What is Hisamitsu Pharmaceutical Co Revenue?

Hisamitsu Pharmaceutical Co's revenue for the three months ended in Aug. 2024 was 円39,646 Mil. Its revenue for the trailing twelve months (TTM) ended in Aug. 2024 was 円150,185 Mil. Hisamitsu Pharmaceutical Co's Revenue per Share for the three months ended in Aug. 2024 was 円539.73. Its Revenue per Share for the trailing twelve months (TTM) ended in Aug. 2024 was 円1,997.64.

During the past 12 months, the average Revenue per Share Growth Rate of Hisamitsu Pharmaceutical Co was 15.40% per year. During the past 3 years, the average Revenue per Share Growth Rate was 9.50% per year. During the past 5 years, the average Revenue per Share Growth Rate was 0.70% per year. During the past 10 years, the average Revenue per Share Growth Rate was -1.30% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get other companies' revenue growth rate using Revenue per Share data.

During the past 13 years, Hisamitsu Pharmaceutical Co's highest 3-Year average Revenue per Share Growth Rate was 13.40% per year. The lowest was -7.60% per year. And the median was 3.90% per year.


Hisamitsu Pharmaceutical Co Revenue Historical Data

The historical data trend for Hisamitsu Pharmaceutical Co's Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hisamitsu Pharmaceutical Co Revenue Chart

Hisamitsu Pharmaceutical Co Annual Data
Trend Feb15 Feb16 Feb17 Feb18 Feb19 Feb20 Feb21 Feb22 Feb23 Feb24
Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 140,992.00 114,510.00 120,193.00 128,330.00 141,706.00

Hisamitsu Pharmaceutical Co Quarterly Data
Nov19 Feb20 May20 Aug20 Nov20 Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24 May24 Aug24
Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 34,881.00 35,850.00 38,879.00 35,810.00 39,646.00

Competitive Comparison of Hisamitsu Pharmaceutical Co's Revenue

For the Drug Manufacturers - Specialty & Generic subindustry, Hisamitsu Pharmaceutical Co's Revenue, along with its competitors' market caps and Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Hisamitsu Pharmaceutical Co's Revenue Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Hisamitsu Pharmaceutical Co's Revenue distribution charts can be found below:

* The bar in red indicates where Hisamitsu Pharmaceutical Co's Revenue falls into.



Hisamitsu Pharmaceutical Co Revenue Calculation

Also referred as sales, revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top.

Revenue for the trailing twelve months (TTM) ended in Aug. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was 円150,185 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Hisamitsu Pharmaceutical Co  (TSE:4530) Revenue Explanation

In ranking the predictability, companies with more consistent revenue and earnings growth are ranked high with predictability.

Peter Lynch categorized companies according to their revenue growth:


Slow Grower: Inflation < 10-Year Revenue Growth Rate < 10%:
Stalwart: 10% < 10-Year Revenue Growth Rate < 20%:
Fast Grower: 10-Year Revenue Growth Rate > 20%:

His favorite companies are stalwart, those growing between 10-20% a year.

Companies in cyclical industries may see their revenue fluctuate wildly in good years and bad years.


Be Aware

Revenue can be manipulated by changing the way how revenue is booked. Companies may book sales before the payment is received, or before the revenue is fully earned. These will be added to balance sheet items such as account payable or account receivables.


Hisamitsu Pharmaceutical Co Revenue Related Terms

Thank you for viewing the detailed overview of Hisamitsu Pharmaceutical Co's Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Hisamitsu Pharmaceutical Co Business Description

Traded in Other Exchanges
Address
408 Tashiro Daikan-machi, Tosu, Saga, JPN, 841-0017
Hisamitsu Pharmaceutical Co Inc is a major pharmaceutical products manufacturer in Japan. The company collaborates with its subsidiaries and associates in operating its business across two segments, The Medical and Related Product segment and the Others segment. The Medical segment represents the company's foremost revenue generating operations. It markets drugs under the Salanpas, Salonsip, Lifecella, Mohrus and Keplat brands, which mainly serve topical medication needs with pain relief creams, gels, sprays, lotions and ointments. The Others segment refers to its miscellaneous businesses such as cable television broadcasting, internet connection, packing materials and insurance. Apart from its primary market in Japan, Hisamitsu has a reach across other regions like North America.

Hisamitsu Pharmaceutical Co Headlines

No Headlines